Clinical Trial Update: Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial of ziprasidone in adolescents with schizophrenia was terminated; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Ziprasidone (ziprasidone)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED | Results posted: 2010-04-13